PRINCETON, NJ – (April 24, 2019) Systech, a global leader in supply chain security and brand protection, along with key strategic partners, has been confirmed to participate in a Food and Drug Administration (FDA) pilot program under the Drug Supply Chain Security Act (DSCSA).

The program is intended to assist drug supply chain stakeholders in developing the future DSCSA electronic, interoperable system to identify and trace prescription drugs as they are distributed within the United States.

Systech partners comprising the Optimal Solution pilot team include RxTransparent, FarmaTrust, T-Systems, Cryptowerk and CalQLogic. Systech CEO, Ara Ohanian, says “The DSCSA is the shield that protects Americans from counterfeit and suspect drugs. By leveraging our advanced technologies, this pilot approach addresses product safety and trust issues beyond compliance. We believe we are creating a unique comprehensive solution with an unmatched combination of partners.”

The collective approach meets regulatory requirements and delivers additional benefit including:

“No single company provides an end to end solution that meets every DSCSA requirement while providing enhanced security and safety for pharmaceutical products. The pilot team intends to demonstrate what is possible using innovative technologies and showcasing capabilities that could ensure the U.S. drug supply chain is the safest in the world,” says Jim Lee, SVP Product Management at Systech. The pilot duration is proposed as six months with the final FDA presentation anticipated for Fall 2019.

The Optimal Solutions team is hosting a live complimentary webinar on April 30th, 1:00 PM EDT to discuss the pilot submission.